Empfehlung
19,4
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
45.3
1 Insider, 870K $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Elevance Health, Inc. |
|---|---|
| Ticker | ELV |
| CIK | 0001156039 |
Branche
| SIC-Code | 6324 |
|---|---|
| Beschreibung | Hospital & Medical Service Plans |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Elevance Health, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:22:33.87774 |
|---|
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 199,125,000,000 | 5,662,000,000 | 25.21 | 121,494,000,000 | 43,882,000,000 |
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | SCHULMAN AMY W | Director | Open Market Sale | -26 | 287.50 | -7,475.00 | -0,8% | |
| 2026-03-06 | Kendrick Charles Morgan JR | Officer, EVP & President, Commercial | Open Market Sale | -3,196 | 284.92 | -910,604.32 | -96,4% | |
| 2026-03-05 | COLLIS STEVEN H | Director | Open Market Purchase | 3,000 | 289.84 | 869,520.00 | +92,1% | |
| 2025-08-19 | DeVore Susan D. | Director | Open Market Purchase | 1,200 | 312.15 | 374,580.00 | +39,7% | |
| 2025-07-18 | BOUDREAUX GAIL | Director, Officer, President and CEO | Open Market Purchase | 5,116 | 287.12 | 1,468,905.92 | +155,5% | |
| 2025-07-18 | BOUDREAUX GAIL | Director, Officer, President and CEO | Open Market Purchase | 1,050 | 287.96 | 302,358.00 | +32,0% | |
| 2025-07-18 | BOUDREAUX GAIL | Director, Officer, President and CEO | Open Market Purchase | 2,334 | 286.07 | 667,687.38 | +70,7% | |
| 2025-04-24 | Kaye Mark | Officer, EVP & CFO | Open Market Sale | -4,588 | 424.82 | -1,949,074.16 | -206,4% | |
| 2025-04-24 | Kaye Mark | Officer, EVP & CFO | Open Market Sale | -4,588 | 424.82 | -1,949,074.16 | -206,4% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.